Amesite Inc. (AMST): Nasdaq/NYSE listing notice — Amesite (AMST) receives Nasdaq delisting notice for failure to meet $2.5M stockholders' equity rule

Amesite Inc.

Received Nasdaq deficiency letter on Nov 26, 2024 for non-compliance with Listing Rule 5550(b)(1) requiring $2.5M stockholders' equity.
Company has 45 calendar days to submit a compliance plan to Nasdaq; it intends to submit such plan.
If plan accepted, Nasdaq may grant up to 180-day extension; if not, Company can request hearing to stay delisting.
Trading of common stock (AMST) continues as normal on Nasdaq Capital Market pending the process.
Company warns there is no assurance it will regain compliance or remain listed.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Amesite Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

November 26, 2024, Amesite Inc. (“Amesite” or “the Company”) received a deficiency letter (the “Nasdaq Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires the Company to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing on the Nasdaq Capital Market (the “Stockholders’ Equity Requirement”), nor is it in compliance with either of the alternative listing standards, either a market value of listed securities of at least $35 mi

View on SEC.gov

Browse all listing & compliance notices →

Amesite Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-105073

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.